Miromatrix Medical Performance
| MIRODelisted Stock | USD 1.49 0.22 12.87% |
The company secures a Beta (Market Risk) of 0.53, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Miromatrix Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Miromatrix Medical is expected to be smaller as well. Miromatrix Medical right now secures a risk of 0.0%. Please verify Miromatrix Medical value at risk, as well as the relationship between the skewness and day median price , to decide if Miromatrix Medical will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Miromatrix Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Miromatrix Medical is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 53.6 M |
Miromatrix |
Miromatrix Medical Relative Risk vs. Return Landscape
If you would invest 149.00 in Miromatrix Medical on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Miromatrix Medical or generate 0.0% return on investment over 90 days. Miromatrix Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Miromatrix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Miromatrix Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Miromatrix Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Miromatrix Medical, and traders can use it to determine the average amount a Miromatrix Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MIRO |
Based on monthly moving average Miromatrix Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Miromatrix Medical by adding Miromatrix Medical to a well-diversified portfolio.
Miromatrix Medical Fundamentals Growth
Miromatrix Stock prices reflect investors' perceptions of the future prospects and financial health of Miromatrix Medical, and Miromatrix Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Miromatrix Stock performance.
| Return On Equity | -1.14 | |||
| Return On Asset | -0.56 | |||
| Operating Margin | (593.69) % | |||
| Current Valuation | 80.11 M | |||
| Shares Outstanding | 27.42 M | |||
| Price To Book | 5.98 X | |||
| Price To Sales | 97.02 X | |||
| Revenue | 953.47 K | |||
| EBITDA | (29.91 M) | |||
| Cash And Equivalents | 32.67 M | |||
| Cash Per Share | 1.56 X | |||
| Total Debt | 3.55 M | |||
| Debt To Equity | 0.1 % | |||
| Book Value Per Share | 0.57 X | |||
| Cash Flow From Operations | (26.68 M) | |||
| Earnings Per Share | (1.14) X | |||
| Total Asset | 34.76 M | |||
| Retained Earnings | (104.01 M) | |||
About Miromatrix Medical Performance
By examining Miromatrix Medical's fundamental ratios, stakeholders can obtain critical insights into Miromatrix Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Miromatrix Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota. Miromatrix Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people.Things to note about Miromatrix Medical performance evaluation
Checking the ongoing alerts about Miromatrix Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Miromatrix Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Miromatrix Medical is not yet fully synchronised with the market data | |
| Miromatrix Medical may become a speculative penny stock | |
| Miromatrix Medical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 953.47 K. Net Loss for the year was (29.96 M) with loss before overhead, payroll, taxes, and interest of (466.93 K). | |
| Miromatrix Medical currently holds about 32.67 M in cash with (26.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.56, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 24.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Miromatrix Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Miromatrix Medical's stock is overvalued or undervalued compared to its peers.
- Examining Miromatrix Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Miromatrix Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Miromatrix Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Miromatrix Medical's stock. These opinions can provide insight into Miromatrix Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Miromatrix Stock
If you are still planning to invest in Miromatrix Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Miromatrix Medical's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |